Israel’s InSightec is in the midst of transforming the operating room with its ExAblate MRI-guided high-intensity ultrasound technology. It has Gynecology and oncology uses. ExAblate O.R. is already being used in several countries, including Europe and the United States, to treat uterine fibroids and pain caused by bone cancer.
“We started with uterine fibroids, which afflict a quarter of all women sometime in their lives and usually are treated with a hysterectomy,” says InSightec president and founder Kobi Vortman. “We believe for patients looking for alternative treatment to preserve the uterus, this is effective and safe.” More than 9,000 patients in the United States, Europe and Asia have been able to avoid surgery as the Israeli technology has successfully destroyed fibroids through ultrasound. A two-venue study begun in January at the Mayo Clinic and at Duke University is…
